ID

14095

Description

Targeted Small Airways Therapy in Persistent Asthma; ODM derived from: https://clinicaltrials.gov/show/NCT01894048

Link

https://clinicaltrials.gov/show/NCT01894048

Keywords

Versions (1)
  1. 3/29/16 3/29/16 -
Uploaded on

March 29, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Asthma NCT01894048

English

Eligibility Asthma NCT01894048

1 forms  
  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT01894048
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
male and female volunteers aged 18-65, with persistent asthma
Description

Age | Gender | Persistent asthma

Data type

boolean

Alias
UMLS CUI [1,1]
C0001779
UMLS CUI [1,2]
C0079399
UMLS CUI [1,3]
C3266628
asthma control questionnaire score >1.0 (at end of run-in)
Description

Score | Asthma control questionnaire

Data type

boolean

Alias
UMLS CUI [1,1]
C0449820
UMLS CUI [1,2]
C2919686
fev1 >60 percent predicted
Description

FEV1

Data type

boolean

Alias
UMLS CUI [1]
C0748133
r5>130% predicted and r5-r20>0.03kpa/l/s
Description

Total airway resistance | Airway Resistance | Small airways

Data type

boolean

Alias
UMLS CUI [1,1]
C0232024
UMLS CUI [1,2]
C0001884
UMLS CUI [1,3]
C1862763
ability to perform spirometry, impulse oscillometry, bronchial challenge and all domiciliary measurements
Description

Ability | Spirometry | impulse oscillometry | Bronchial Provocation Tests | Domiciliary Measurement

Data type

boolean

Alias
UMLS CUI [1,1]
C0085732
UMLS CUI [1,2]
C0037981
UMLS CUI [1,3]
C3517156
UMLS CUI [1,4]
C0006265
UMLS CUI [1,5]
C0242485
UMLS CUI [1,6]
C0338047
ability to give informed consent
Description

Ability | Informed Consent

Data type

boolean

Alias
UMLS CUI [1,1]
C0085732
UMLS CUI [1,2]
C0021430
asthmatic patients receiving treatment at step 2, 3, or 4 of british thoracic society asthma guidelines
Description

Asthma | Therapeutic procedure | treatment guideline

Data type

boolean

Alias
UMLS CUI [1,1]
C0004096
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C0935576
ability to withhold long-acting beta-agonists for the duration of the study
Description

Ability | Withholding Treatment | Adrenergic beta-Agonists

Data type

boolean

Alias
UMLS CUI [1,1]
C0085732
UMLS CUI [1,2]
C0871549
UMLS CUI [1,3]
C0001644
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients already receiving extra-fine particle inhaled corticosteroids (qvar, fostair, alvesco)
Description

inhaled steroids

Data type

boolean

Alias
UMLS CUI [1,1]
C2065041
UMLS CUI [1,2]
C0731268
UMLS CUI [2]
C1174745
pregnancy or lactation
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
known or suspected sensitivity to the investigational medicinal product
Description

Hypersensitivity | Investigational New Drugs

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
inability to comply with protocol
Description

Compliance behavior | Limited

Data type

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0439801
any clinically significant medical conditions that may either endanger the health or safety of the participant, or jeopardise the protocol
Description

Compliance behavior | Limited | Comorbidity

Data type

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
an asthma exacerbation requiring systemic steroid therapy or lower respiratory tract infection requiring antibiotics within 3 months prior to study commencement
Description

Exacerbation of asthma | systemic steroids | Lower respiratory tract infection | Antibiotics

Data type

boolean

Alias
UMLS CUI [1,1]
C0349790
UMLS CUI [1,2]
C0332121
UMLS CUI [1,3]
C2825233
UMLS CUI [2,1]
C0149725
UMLS CUI [2,2]
C0003232
participation in previous trial within 30 days
Description

Study Subject Participation Status

Data type

boolean

Alias
UMLS CUI [1]
C2348568
Back to the top of the page

Similar models

Eligibility Asthma NCT01894048

1 forms
  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT01894048
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age | Gender | Persistent asthma
Item
male and female volunteers aged 18-65, with persistent asthma
boolean
C0001779 (UMLS CUI [1,1])
C0079399 (UMLS CUI [1,2])
C3266628 (UMLS CUI [1,3])
Score | Asthma control questionnaire
Item
asthma control questionnaire score >1.0 (at end of run-in)
boolean
C0449820 (UMLS CUI [1,1])
C2919686 (UMLS CUI [1,2])
FEV1
Item
fev1 >60 percent predicted
boolean
C0748133 (UMLS CUI [1])
Total airway resistance | Airway Resistance | Small airways
Item
r5>130% predicted and r5-r20>0.03kpa/l/s
boolean
C0232024 (UMLS CUI [1,1])
C0001884 (UMLS CUI [1,2])
C1862763 (UMLS CUI [1,3])
Ability | Spirometry | impulse oscillometry | Bronchial Provocation Tests | Domiciliary Measurement
Item
ability to perform spirometry, impulse oscillometry, bronchial challenge and all domiciliary measurements
boolean
C0085732 (UMLS CUI [1,1])
C0037981 (UMLS CUI [1,2])
C3517156 (UMLS CUI [1,3])
C0006265 (UMLS CUI [1,4])
C0242485 (UMLS CUI [1,5])
C0338047 (UMLS CUI [1,6])
Ability | Informed Consent
Item
ability to give informed consent
boolean
C0085732 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])
Asthma | Therapeutic procedure | treatment guideline
Item
asthmatic patients receiving treatment at step 2, 3, or 4 of british thoracic society asthma guidelines
boolean
C0004096 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0935576 (UMLS CUI [1,3])
Ability | Withholding Treatment | Adrenergic beta-Agonists
Item
ability to withhold long-acting beta-agonists for the duration of the study
boolean
C0085732 (UMLS CUI [1,1])
C0871549 (UMLS CUI [1,2])
C0001644 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
inhaled steroids
Item
patients already receiving extra-fine particle inhaled corticosteroids (qvar, fostair, alvesco)
boolean
C2065041 (UMLS CUI [1,1])
C0731268 (UMLS CUI [1,2])
C1174745 (UMLS CUI [2])
Pregnancy | Breast Feeding
Item
pregnancy or lactation
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Hypersensitivity | Investigational New Drugs
Item
known or suspected sensitivity to the investigational medicinal product
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
Compliance behavior | Limited
Item
inability to comply with protocol
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
Compliance behavior | Limited | Comorbidity
Item
any clinically significant medical conditions that may either endanger the health or safety of the participant, or jeopardise the protocol
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
Exacerbation of asthma | systemic steroids | Lower respiratory tract infection | Antibiotics
Item
an asthma exacerbation requiring systemic steroid therapy or lower respiratory tract infection requiring antibiotics within 3 months prior to study commencement
boolean
C0349790 (UMLS CUI [1,1])
C0332121 (UMLS CUI [1,2])
C2825233 (UMLS CUI [1,3])
C0149725 (UMLS CUI [2,1])
C0003232 (UMLS CUI [2,2])
Study Subject Participation Status
Item
participation in previous trial within 30 days
boolean
C2348568 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial